SCHEMBL10702082

SCHEMBL10702082

COc1cc2c(cc1Sc1ccccc1)CCN(C(=O)C(F)(F)F)CC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.50
▸ ESR2 Q92731 2/20 0.50
▸ HSD17B10 Q99714 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ MTNR1B P49286 1/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ HCRTR2 O43614 6/20 0.43
▸ HCRTR1 O43613 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ GPR183 P32249 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL10700510 0.79 SMN1; SMN2 (0.52) HSD17B10KMT2AKDM4ENPC1ALOX15
Fumaric Acid SCHEMBL10700517 0.79 SMN1; SMN2 (0.52) HSD17B10KMT2AKDM4ENPC1ALOX15
Hydrochloric Acid SCHEMBL10703667 0.79 DRD1 (0.55) CYP3A4
SCHEMBL5329746 0.76 ESR1 (0.56) ESR1ESR2HSD17B10KMT2AKDM4E
SCHEMBL10703630 0.76 ESR1 (0.48) ESR1ESR2HSD17B10KMT2AKDM4E
SCHEMBL2061259 0.75 ESR1 (0.55) ESR1ESR2HSD17B10KMT2AKDM4E
SCHEMBL21255989 0.75 ESR1 (0.69) ESR1ESR2HSD17B10KMT2AKDM4E
SCHEMBL12438368 0.74 ESR1 (0.54) ESR1ESR2HSD17B10KMT2AKDM4E
SCHEMBL10746175 0.73 CYP3A4 (0.53) ESR1ESR2HSD17B10KDM4ENPC1
SCHEMBL10345334 0.72 CYP3A4 (0.53) ESR1ESR2HSD17B10KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0285287-A2 3-Benzazepine compounds for use in treating gastrointestinal motility disorders SMITHKLINE BEECHAM CORPORATION (US) 1988-10-05 — — EP disclosed
Send feedback